{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:40:15Z","timestamp":1792309215850,"version":"4.4.0"},"reference-count":23,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Urologia"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Bacterial biofilms play a key role in antibiotic resistance, infection recurrence, and reduced pathogen detection in prostatic secretion. Bovhyaluronidase azoximer is a biofilm-disrupting agent. This trial aimed to evaluate its effects on biofilms and clinical outcomes in patients with chronic prostatitis and associated infertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients with chronic bacterial prostatitis and infertility completed the NIH-CPSI, IPSS, and QoL questionnaires, underwent microbiological culture of prostatic secretion, ejaculate, or the third portion of urine, light and electron microscopy of ejaculate before and after treatment. Patients were randomized into two groups treated with antibiotics combined with bovhyaluronidase azoximer, and antibiotics alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The experimental group showed greater improvements on the NIH-CPSI scale (MD \u22123.04, 95%CI: \u22123.77 to \u22122.3,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Significant reduction in bacterial colony count and neutrophil levels were detected in the experimental group. Ejaculate clearance from neutrophils and bacteria was more frequent in experimental group (41% vs 7.2%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.01; 41.7% vs 12.1%,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.043). Electron microscopy revealed disappearance of the intercellular matrix of bacterial microcolonies only in the experimental group. Recurrence rates were significantly lower at both 6\u2009months and 12\u2009months in the experimental group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The combined use of bovhyaluronidase azoximer with antibiotics significantly improved symptoms, reduced leukocyte and bacterial counts, and lowered recurrence rates in patients with chronic prostatitis. Post-treatment microscopy confirmed the disruption of biofilm structures, suggesting enhanced microbial clearance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03915603261453123","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:53:42Z","timestamp":1781679222000},"page":"767-776","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A randomized controlled trial on the impact of bovhyaluronidase azoximer on ejaculate biofilms in patients with chronic prostatitis"],"prefix":"10.1177","volume":"93","author":[{"given":"Morozov","family":"Andrey","sequence":"first","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6606-147X","authenticated-orcid":false,"given":"Vovdenko","family":"Stanislav","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bragina","family":"Elizaveta","sequence":"additional","affiliation":[{"name":"A.N. Belozersky Research Institute of Physico-Chemical Biology MSU, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boldyreva","family":"Margarita","sequence":"additional","affiliation":[{"name":"NRC Institute of Immunology FMBA of Russia, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhitaryan","family":"Ofelia","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubkov","family":"Dmitry","sequence":"additional","affiliation":[{"name":"NPO Petrovax Pharm LLC, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allenov","family":"Sergey","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-8187","authenticated-orcid":false,"given":"Korolev","family":"Dmitry","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokimov","family":"Mikhail","sequence":"additional","affiliation":[{"name":"Semeynaya Poliklinika LLC, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapoport","family":"Leonid","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazimiev","family":"Magomed","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spivak","family":"Leonid","sequence":"additional","affiliation":[{"name":"Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Hilt EE McKinley K Pearce MM et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol 2014; 52(3): 871\u2013876. https:\/\/doi.org\/10.1128\/JCM.02876-13","DOI":"10.1128\/JCM.02876-13"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Wolfe AJ Toh E Shibata N et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 2012; 50(4): 1376\u20131383. https:\/\/doi.org\/10.1128\/JCM.05852-11","DOI":"10.1128\/JCM.05852-11"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Anothaisintawee T. Management of chronic prostatitis\/chronic pelvic pain syndrome. JAMA 2011; 305(1): 78. https:\/\/doi.org\/10.1001\/jama.2010.1913","DOI":"10.1001\/jama.2010.1913"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Cottell E Harrison RF McCaffrey M et al. Are seminal fluid microorganisms of significance or merely contaminants? Fertil Steril 2000; 74(3): 465\u2013470. https:\/\/doi.org\/10.1016\/S0015-0282(00)00709-3","DOI":"10.1016\/S0015-0282(00)00709-3"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Rodin DM Larone D Goldstein M. Relationship between semen cultures leukospermia and semen analysis in men undergoing fertility evaluation. Fertil Steril 2003; 79 suppl 3: 1555\u20131558. https:\/\/doi.org\/10.1016\/S0015-0282(03)00340-6","DOI":"10.1016\/S0015-0282(03)00340-6"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Vestby LK Gr\u00f8nseth T Simm R et al. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics 2020; 9(2): 59. https:\/\/doi.org\/10.3390\/antibiotics9020059","DOI":"10.3390\/antibiotics9020059"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Tsukanov AY Satybaldin DO Semikina SP. [Improvement of performance of semen culture in infertile men undergone to diagnostic evaluation]. Urologiia 2019; 6_2020(6): 26\u201330. https:\/\/doi.org\/10.18565\/urology.2019.6.26-30","DOI":"10.18565\/urology.2019.6.26-30"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","unstructured":"Henkel R Offor U Fisher D. The role of infections and leukocytes in male infertility. Andrologia 2021; 53(1): e13743. https:\/\/doi.org\/10.1111\/and.13743","DOI":"10.1111\/and.13743"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"Shoskes DA Nickel JC. Classification and treatment of men with chronic prostatitis\/chronic pelvic pain syndrome using the UPOINT system. World J Urol 2013; 31(4): 755\u2013760. https:\/\/doi.org\/10.1007\/s00345-013-1075-6","DOI":"10.1007\/s00345-013-1075-6"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.18565\/urology.2020.3.56-62"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","unstructured":"Gatina A Trizna E Kolesnikova A et al. The bovhyaluronidase azoximer (Longidaza\u00ae) disrupts Candida albicans and Candida albicans-bacterial mixed biofilms and increases the efficacy of antifungals. Medicina (B 2022; 58(12): 1710. https:\/\/doi.org\/10.3390\/medicina58121710","DOI":"10.3390\/medicina58121710"},{"key":"e_1_3_2_13_2","unstructured":"Meares EM Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Investig Urol 1968; 5(5): 492\u2013518. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4870505 [Online] (accessed 2022)."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Morozov A Bazarkin A Babaevskaya D et al. A systematic review and meta-analysis of placebo effect in clinical trials on chronic prostatitis\/chronic pelvic pain syndrome. Prostate 2022; 82(6): 633\u2013656. https:\/\/doi.org\/10.1002\/pros.24311","DOI":"10.1002\/pros.24311"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Bud\u00eda A Luis Palmero J Broseta E et al. Value of semen culture in the diagnosis of chronic bacterial prostatitis: a simplified method. Scand J Urol Nephrol 2006; 40(4): 326\u2013331. https:\/\/doi.org\/10.1080\/00365590600748247","DOI":"10.1080\/00365590600748247"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Flemming H-C Wingender J. The biofilm matrix. Nat Rev Microbiol 2010; 8(9): 623\u2013633. https:\/\/doi.org\/10.1038\/nrmicro2415","DOI":"10.1038\/nrmicro2415"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Rather MA Gupta K Mandal M. Microbial biofilm: formation architecture antibiotic resistance and control strategies. Braz J Microbiol 2021; 52(4): 1701\u20131718. https:\/\/doi.org\/10.1007\/s42770-021-00624-x","DOI":"10.1007\/s42770-021-00624-x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Roy R Tiwari M Donelli G et al. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence 2018; 9(1): 522\u2013554. https:\/\/doi.org\/10.1080\/21505594.2017.1313372","DOI":"10.1080\/21505594.2017.1313372"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Lundin PM Fiser BL Blackledge MS et al. Functionalized self-assembled monolayers: versatile strategies to combat bacterial biofilm formation. Pharmaceutics 2022; 14(8): 1613. https:\/\/doi.org\/10.3390\/pharmaceutics14081613","DOI":"10.3390\/pharmaceutics14081613"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Ghosh A Jayaraman N Chatterji D. Small-molecule inhibition of bacterial biofilm. ACS Omega 2020; 5(7): 3108\u20133115. https:\/\/doi.org\/10.1021\/acsomega.9b03695","DOI":"10.1021\/acsomega.9b03695"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","unstructured":"Hemmati F Rezaee MA Ebrahimzadeh S et al. Novel strategies to combat bacterial biofilms. Mol Biotechnol 2021; 63(7): 569\u2013586. https:\/\/doi.org\/10.1007\/s12033-021-00325-8","DOI":"10.1007\/s12033-021-00325-8"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Parrino B Schillaci D Carnevale I et al. Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. Eur J Med Chem 2019; 161: 154\u2013178. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.036","DOI":"10.1016\/j.ejmech.2018.10.036"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Bizzarri FP Campetella M Ragonese M et al. The role of alternative medicine and complimentary therapies in urologic disease: new horizons. Urologia 2024; 91(4): 641\u2013646. https:\/\/doi.org\/10.1177\/03915603241258697","DOI":"10.1177\/03915603241258697"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Kotov SV Bolotov AD Belomyttsev SV et al. [Multicenter randomized study of bovhyalu-ronidase azoximer (longidaza) in men after transuretral resection of the prostate]. Urologiia 2021; 10(3): 61\u201369. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34251103 [Online] (accessed 2022).","DOI":"10.18565\/urology.2021.3.61-69"}],"container-title":["Urologia Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261453123","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03915603261453123","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03915603261453123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T07:07:04Z","timestamp":1792307224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03915603261453123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/03915603261453123"],"URL":"https:\/\/doi.org\/10.1177\/03915603261453123","relation":{},"ISSN":["0391-5603","1724-6075"],"issn-type":[{"value":"0391-5603","type":"print"},{"value":"1724-6075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}